Daniel Spoon, M.D., shares how Providence is innovating through a revolution in cardiac care through Cardioscope.
Home
»
Innovation Institute
»
Providence Institute for Clinical Innovation shares how innovation impacts patients
Most Recent Articles
New Study: Why this breakthrough in pig-to-human kidney research matters
A new Providence-led study published in Nature offers one of the most detailed looks yet at what actually happens inside the body after a pig kidney is transplanted into a human.
New Providence study identifies key risk factors for early-onset colorectal Cancer
A Cross-Sectional Retrospective Case-Control Study on Predictors of Early Onset Colorectal Cancer in a Multi-State Community Health System.
Geno4ME Study Show How Whole Genome Sequencing May Impact Routine Genetic Screening
Population genetic screening is evolving beyond targeted panels as next-generation sequencing (NGS) technology makes whole genome sequencing (WGS) more efficient and accessible
New AI Model Shows Potential for Revolutionizing Clinical Trials and Generating Real World Evidence
New research recently published in the New England Journal of Medicine begs the question: Can an AI-based model revolutionize clinical research?
Providence whole genome sequencing program shows transformative potential for population health
A new study from researchers at Providence, published in Nature NPJ Genomic Medicine, demonstrates how Whole Genome Sequencing (WGS) can transform health care
Providence weighs in: How genetic testing is reshaping everyday care
Genetic testing has moved beyond academic centers to being reflected in clinical guidelines adopted by a growing number of clinicians
Two immune patterns help predict how head and neck cancer patients respond to immunotherapy
New Providence research published in Nature-Precision Oncology finds that in head and neck cancer, researchers found that two specific immune response patterns
Introducing BiomedParse: A new AI foundation model for faster, smarter, all-in-one image analysis
A wide variety of medical imaging tools (CT,MRI, pathology etc.) are used in routine medical care, and represent robust datasets for potential biomedical discovery using Artificial Intelligence (AI)
Break through Research Early sequencing offers a 67% chance of changing treatments and improved survival.
Research from a team led by Brian Piening, PhD, Program Director for Providence Genomics that included colleagues from across Providence as well as collaborators at Illumina and Microsoft
Early Detection for More Patients: Prevention4ME expands and includes more data
Prevention4ME has identified more than 2600 patients at high risk for cancer who are now being screened differently or receiving NCCN guideline-recommended genetic testing
Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection
Providence Genomics and Providence-Swedish Cancer Institute have launched the PREVAIL study,
Comprehensive Genomic Profiling leads to better patient outcomes, a new joint study says
Widespread Adoption of Precision Anticancer Therapies After Implementation of Pathologist-Directed Comprehensive Genomic Profiling Across a Large US Health System
Providence Contribution to Novel AI Model Opens the Door to Accelerating Clinical Discovery and Advancing Patient Care
This research highlights a new artificial intelligence model that Providence, Microsoft, and the University of Washington used to diagnose cancer.
Everett-Based Providence Comprehensive Breast Center Launches Free, Personalized Cancer Screening and Early Detection Program
Everett-based Providence Comprehensive Breast Center is the first program in Providence’s seven-state health system to launch a free, personalized cancer screening and early detection system.
New Research Evaluates the Success and Challenges of Novel Transplant Treatment
Xenotransplantation—the grating or transplanting of organs or tissues between members of different species
Digital Pathology (DP) Using AI is Transforming Analysis & Diagnosis in Clinical Practice
This innovative Artificial Intelligence (AI) technology involves the digitization of traditional glass slides which enables pathologists to access, analyze, and share high-resolution whole-slide image
Understanding the Progression of Ductal Carcinoma in Situ (DCIS) to Invasive Breast Cancer (IBC)
This study includes authors from Providence Genomics in collaboration with Providence Swedish Cancer Institute.
Using Cancer Risk Screening Assessments in Routine Care to Personalize Care Planning and Genetic Testing Access
An estimated 90 percent of individuals with inherited cancer risk do not know they are at risk.
Study Shows Genomic Testing Can Improve Outcomes for those with Advanced Cancer
Providence Genomics and EACRI researchers conducted a multi-year study of the impact of removing testing barriers to comprehensive genomic profiling (CGP) for patients with advanced cancers.